CHN - DENGUE FEVER (GROUP 5)

Question 1

Dengue fever, caused by the ,____
poses severe health risks, ranging from mild symptoms to life-threatening
complications

Answer 1

Aedes aegypti and Aedes albopictus mosquitoes

Question 2

Is the fastest-spreading
vector-borne disease globally

Answer 2

Dengue

Question 3

The dengue virus has four stereotypes:

Answer 3

dengue-1 DENV1, dengue-2 DENV2,
dengue-3 DENV3, and dengue-4 DENV4.

Question 4

Most people with dengue experience mild or no symptoms and recover within

Answer 4

1–2
weeks

Question 5

If symptoms do occur,
they typically appear ___days after infection and last for ____days

Answer 5

4–10

2–7

Question 6

Common symptoms
include a

Answer 6

high fever (40°C/104°F)

severe headache

pain behind the eyes

muscle and
joint pain

nausea, vomiting

swollen glands

rash.

Question 7

Individuals who are infected for the second time are at

Answer 7

greater risk of severe dengue

Question 8

Severe dengue symptoms often develop after

Answer 8

the fever subsides

Question 9

Severe dengue symptoms

Answer 9

intense abdominal pain

persistent vomiting

rapid breathing,

bleeding from the gums or
nose

extreme fatigue

restlessness

blood in vomit or stoo

excessive thirs

pale and
cold skin, and weakness

Question 10

Diagnostic Methods:
Nucleic Acid Amplification Tests (NAATs)

Answer 10

identify the genetic material
(RNA) of the dengue virus in blood.

useful during the early
stages of the infection, typically within the first week

(RT-PCR) is a commonly used method
because it is highly accurate.

Question 11

Diagnostic Methods:

Antigen Detection:

Answer 11

detects a specific protein from the dengue
virus in the blood

effective during the first few days of fever and helps diagnose the disease before the body produces antibodies.

Question 12

Diagnostic Methods:
○ Serological Tests:

Answer 12

These tests check for antibodies the immune system creates to
fight dengue.

Question 13

○ Serological Tests:

antibodies appear in the acute phase and indicate a recent infection,

antibodies suggest a past infection or later stage of the illness.

Answer 13

e. IgM
IgG

Question 14

Diagnostic Methods:
Complete Blood Count (CBC):

Answer 14

This test measures levels of blood cells. It can identify
low platelet counts (thrombocytopenia) and low white blood cell counts (leukopenia),
which are common in dengue

Question 15

Diagnostic Methods:
Imaging and Monitoring:

Answer 15

: In severe cases, tools like ultrasound can detect fluid
buildup in the body, which may indicate plasma leakage, a serious complication of
dengue.

Question 16

A vaccine that can help prevent all four dengue viruses (serotypes).

Answer 16

Dengvaxia

Question 17

Dengvaxia is made by

Answer 17

Sanofi Pasteur

Question 18

The dengue vaccine is recommended for routine use among children aged
____ years with laboratory-confirmed previous dengue virus infection and living
in areas where dengue is endemic.

Answer 18

9–16

Question 19

Dengvaxia

Answer 19

The vaccine is a tetravalent, live-attenuated dengue vaccine.

Question 20

National Dengue Prevention and Control Programs

Answer 20

a.) Integrated vector control approach –
b.) Case diagnosis, management and reporting –
c.) Surveillance –

Question 21

The etiologic agent of dengue is the dengue virus
(DENV), a member of the ____ within
the

Answer 21

Flavivirus genus

Flaviviridae family.

Question 22

First
infection with one of the four serotypes usually is
____, while second infection
with one of other serotypes may cause

Answer 22

non-severe or asymptomatic

severe
dengue.

Question 23

REPUBLIC ACT No. 11332

Answer 23

Mandatory Reporting of Notifiable Diseases and
Health Events of Public Health Concern Act

Question 24

Republic Act No. 9003

Answer 24

Ecological Solid Waste Management Act of 2000

Question 25

ENHANCED 4S STRATEGY

Answer 25

S – earch and Destroy
S – eek Early Consultation
S – elf Protection Measures
S – ay yes to fogging only during outbreaks